Beyond lung cancer: air pollution and bladder, breast and prostate cancer incidence
International Journal of Epidemiology · 2024
DOI: 10.1093/ije/dyae093 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2024. Verfasst von Inass Kayyal-Tarabeia und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Health & Environment Research (HER) Lab, Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Air Pollution, Prostatic Neoplasms, Particulate Matter. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Israel Cancer Association, Israel Jacob and Lila Alther Foundation.
Abstract (Originalsprache)
Background
The carcinogenicity of air pollution and its impact on the risk of lung cancer is well known; however, there are still knowledge gaps and mixed results for other sites of cancer.
Methods
The current study aimed to evaluate the associations between ambient air pollution [fine particulate matter (PM2.5) and nitrogen oxides (NOx)] and cancer incidence. Exposure assessment was based on historical addresses of >900 000 participants. Cancer incidence included primary cancer cases diagnosed from 2007 to 2015 (n = 30 979). Cox regression was used to evaluate the associations between ambient air pollution and cancer incidence [hazard ratio (HR), 95% CI].
Results
In the single-pollutant models, an increase of one interquartile range (IQR) (2.11 µg/m3) of PM2.5 was associated with an increased risk of all cancer sites (HR = 1.51, 95% CI: 1.47–1.54), lung cancer (HR = 1.73, 95% CI: 1.60–1.87), bladder cancer (HR = 1.50, 95% CI: 1.37–1.65), breast cancer (HR = 1.50, 95% CI: 1.42–1.58) and prostate cancer (HR = 1.41, 95% CI: 1.31–1.52). In the single-pollutant and the co-pollutant models, the estimates for PM2.5 were stronger compared with NOx for all the investigated cancer sites.
Conclusions
Our findings confirm the carcinogenicity of ambient air pollution on lung cancer and provide additional evidence for bladder, breast and prostate cancers. Further studies are needed to confirm our observation regarding prostate cancer. However, the need for more research should not be a barrier to implementing policies to limit the population's exposure to air pollution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Health & Environment Research (HER) Lab, Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
- The Galilee Society, The Arab National Society for Research and Health, Shefa-Amr, Israel.
- Sharett Institute for Oncology, Hadassah Medical Centre, Jerusalem, Israel.
- The Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
- Department of Geography and Environmental Development, Ben-Gurion University of the Negev, Beer Sheva, Israel.
- Air Quality and Climate Change Division, Israel Ministry of Environmental Protection, Jerusalem, Israel.
ORCID-Profile: Inass Kayyal-Tarabeia, Aviad Zick, Keren Agay-Shay
Förderung
- Israel Cancer Association
- Israel Jacob and Lila Alther Foundation
Zitieren
APA
Kayyal-Tarabeia, I., Zick, A., Kloog, I., Levy, I., Blank, M., & Agay-Shay, K. (2024). Beyond lung cancer: air pollution and bladder, breast and prostate cancer incidence. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyae093
Vancouver
Kayyal-Tarabeia I, Zick A, Kloog I, Levy I, Blank M, Agay-Shay K. Beyond lung cancer: air pollution and bladder, breast and prostate cancer incidence. International Journal of Epidemiology. 2024. doi:10.1093/ije/dyae093
BibTeX
@article{KayyalTarabeia2024,
author = {Kayyal-Tarabeia, Inass and Zick, Aviad and Kloog, Itai and Levy, Ilan and Blank, Michael and Agay-Shay, Keren},
title = {Beyond lung cancer: air pollution and bladder, breast and prostate cancer incidence},
journal = {International Journal of Epidemiology},
year = {2024},
doi = {10.1093/ije/dyae093}
}
EUVIMED